The Clorox Company (NYSE: CLX)recently expanded its health and wellness product portfolio with the acquisition of Nutranext (formerly Wellnext), a Florida-based, vertically-integrated producer of dietary supplements. As a result, the company has gained a foothold in a market that's expected to reach $220 billion worldwide by 2022.
Can Clorox's Steady Appetite for M&A Deliver Long-Term Growth?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться